Static magnetic fields increase tumor microvessel leakiness and improve antitumoral efficacy in combination with paclitaxel

Cancer Letters

Volumn 343, Issue 1, 2014, Pages 107-114

  Gellrich, Donata ^a,b   Becker, Sven ^a,b   Strieth, Sebastian ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Cancer; Chemotherapy; Permeability; Static magnetic fields; Tumor

Indexed keywords

PACLITAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL INTERACTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPOSURE; HAMSTER; LEUKOCYTE; MAGNETIC FIELD; MALE; MICROCIRCULATION; MICROSCOPY; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; SKINFOLD; STATIC MAGNETIC FIELD; TUMOR GROWTH;

CRICETINAE;

EID: 84890859754     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.09.021     Document Type: Article

References (42)

1. Raylman R.R., Clavo A.C., Wahl R.L. Exposure to strong static magnetic field slows the growth of human cancer cells in vitro. Bioelectromagnetics 1996, 17:358-363.
2. Strelczyk D., Eichhorn M.E., Luedemann S., Brix G., Dellian M., Berghaus A., et al. Static magnetic fields impair angiogenesis and growth of solid tumors in vivo. Cancer Biol. Ther. 2009, 8(September):1756-1762.
3. Strieth S., Strelczyk D., Eichhorn M.E., Dellian M., Luedemann S., Griebel J., et al. Static magnetic fields induce blood flow decrease and platelet adherence in tumor microvessels. Cancer Biol. Ther. 2008, 7(June):814-819.
4. Fanelli C., Coppola S., Barone R., Colussi C., Gualandi G., Volpe P., et al. Magnetic fields increase cell survival by inhibiting apoptosis via modulation of Ca2+ influx. FASEB J. 1999, 13(January):95-102.
5. Teodori L., Gohde W., Valente M.G., Tagliaferri F., Coletti D., Perniconi B., et al. Static magnetic fields affect calcium fluxes and inhibit stress-induced apoptosis in human glioblastoma cells. Cytometry 2002, 49(December):143-149.
6. Ruggiero M., Bottaro D.P., Liguri G., Gulisano M., Peruzzi B., Pacini S. 0.2T magnetic field inhibits angiogenesis in chick embryo chorioallantoic membrane. Bioelectromagnetics 2004, 25(July):390-396.
7. Sahebjamei H., Abdolmaleki P., Ghanati F. Effects of magnetic field on the antioxidant enzyme activities of suspension-cultured tobacco cells. Bioelectromagnetics 2007, 28(January):42-47.
8. Zhang Q.M., Tokiwa M., Doi T., Nakahara T., Chang P.W., Nakamura N., et al. Strong static magnetic field and the induction of mutations through elevated production of reactive oxygen species in Escherichia coli soxR. Int. J. Radiat. Biol. 2003, 79(April):281-286.
9. Liu Y., Qi H., Sun R.G., Chen W.F. An investigation into the combined effect of static magnetic fields and different anticancer drugs on K562 cell membranes. Tumori 2011, 97(May-June):386-392.
10. Tofani S., Cintorino M., Barone D., Berardelli M., De Santi M.M., Ferrara A., et al. Increased mouse survival, tumor growth inhibition and decreased immunoreactive p53 after exposure to magnetic fields. Bioelectromagnetics 2002, 23(April):230-238.
11. Tofani S., Barone D., Berardelli M., Berno E., Cintorino M., Foglia L., et al. Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma. Pharmacol. Res. 2003, 48(July):83-90.
12. Gray J.R., Frith C.H., Parker J.D. In vivo enhancement of chemotherapy with static electric or magnetic fields. Bioelectromagnetics 2000, 21(December):575-583.
13. Salvatore J.R., Harrington J., Kummet T. Phase I clinical study of a static magnetic field combined with anti-neoplastic chemotherapy in the treatment of human malignancy: initial safety and toxicity data. Bioelectromagnetics 2003, 24(October):524-527.
14. Chen W.F., Qi H., Sun R.G., Liu Y., Zhang K., Liu J.Q. Static magnetic fields enhanced the potency of cisplatin on k562 cells. Cancer Biother. Radio. 2010, 25(August):401-408.
15. Sun R.G., Chen W.F., Qi H., Zhang K., Bu T., Liu Y., et al. Biologic effects of SMF and paclitaxel on K562 human leukemia cells. Gen. Physiol. Biophys. 2012, 31(March):1-10.
16. Teodori L., Albertini M.C., Uguccioni F., Falcieri E., Rocchi M.B., Battistelli M., et al. Static magnetic fields affect cell size, shape, orientation, and membrane surface of human glioblastoma cells, as demonstrated by electron, optic, and atomic force microscopy. Cytometry A 2006, 69(February):75-85.
17. Pink D.B., Schulte W., Parseghian M.H., Zijlstra A., Lewis J.D. Real-time visualization and quantitation of vascular permeability in vivo: implications for drug delivery. PLoS ONE 2012, 7:e33760.
18. Hobbs S.K., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA 1998, 95(April 14):4607-4612.
19. Asaishi K., Endrich B., Gotz A., Messmer K. Quantitative analysis of microvascular structure and function in the amelanotic melanoma A-Mel-3. Cancer Res. 1981, 41(May):1898-1904.
20. Endrich B., Asaishi K., Gotz A., Messmer K. Technical report-a new chamber technique for microvascular studies in unanesthetized hamsters. Res. Exp. Med. (Berl.) 1980, 177:125-134.
21. Endrich B., Hammersen F., Gotz A., Messmer K. Microcirculatory blood flow, capillary morphology and local oxygen pressure of the hamster amelanotic melanoma A-Mel-3. J. Natl. Cancer Inst. 1982, 68(March):475-485.
22. Brix G., Strieth S., Strelczyk D., Dellian M., Griebel J., Eichhorn M.E., et al. Static magnetic fields affect capillary flow of red blood cells in striated skin muscle. Microcirculation 2008, 15(January):15-26.
23. Zeintl H., Tompkins W.R., Messmer K., Intaglietta M. Static and dynamic microcirculatory video image analysis applied to clinical investigations. Prog. Appl. Microcirculat. 1986, 5:1-10.
24. Klyscz T., Junger M., Jung F., Zeintl H. Cap image-a new kind of computer-assisted video image analysis system for dynamic capillary microscopy. Biomed. Tech. (Berl.) 1997, 42(June):168-175.
25. Baker M., Wayland H. On-line volume flow rate and velocity profile measurement for blood in microvessels. Microvasc. Res. 1974, 7(January):131-143.
26. Yuan F., Leunig M., Berk D.A., Jain R.K. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc. Res. 1993, 45(May):269-289.
27. Michel C.C., Curry F.E. Microvascular permeability. Physiol. Rev. 1999, 79(July):703-761.
28. Tozer G.M., Prise V.E., Wilson J., Cemazar M., Shan S., Dewhirst M.W., et al. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Cancer Res. 2001, 61(September):6413-6422.
29. Langley R.R., Russell J., Eppihimer M.J., Alexander S.J., Gerritsen M., Specian R.D., et al. Quantification of murine endothelial cell adhesion molecules in solid tumors. Am. J. Physiol. 1999, 277(September):H1156-H1166.
30. Webb R.C., Bohr D.F. Mechanism of membrane stabilization by calcium in vascular smooth muscle. Am. J. Physiol. 1978, 235(November):C227-C232.
31. Soltis E.E., Field F.P. Sodium pump activity and calcium relaxation in vascular smooth muscle of deoxycorticosterone acetate-salt rats. Hypertension 1986, 8(November):1032-1039.
32. Nikolic L., Todorovic N., Zakrzewska J., Stanic M., Raus S., Kalauzi A., et al. Involvement of Na+/K+ pump in fine modulation of bursting activity of the snail Br neuron by 10mT static magnetic field. J. Comput. Physiol. A: Neuroethol. Sens. Neural. Behav. Physiol. 2012, 198(July):525-540.
33. Higashi T., Yamagishi A., Takeuchi T., Kawaguchi N., Sagawa S., Onishi S., et al. Orientation of erythrocytes in a strong static magnetic field. Blood 1993, 82(August 15):1328-1334.
34. Chang Y.S., di Tomaso E., McDonald D.M., Jones R., Jain R.K., Munn L.L. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc. Natl. Acad. Sci. USA 2000, 97(December 19):14608-14613.
35. Yamamoto T., Nagayama Y., Tamura M. A blood-oxygenation-dependent increase in blood viscosity due to a static magnetic field. Phys. Med. Biol. 2004, 49(July 21):3267-3277.
36. McDonald D.M., Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res. 2002, 62(September 15):5381-5385.
37. Marrocco B.J., Drost D.J., Prato F.S. An optimized head coil design for MR imaging at 0.15T. Magn. Reson. Med. 1987, 5(August):143-159.
38. Colevas A.D. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. J. Clin. Oncol. 2006, 24(June 10):2644-2652.
39. Widder K.J., Morris R.M., Poore G., Howard D.P., Senyei A.E. Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin. Proc. Natl. Acad. Sci. USA 1981, 78(January):579-581.
40. Alexiou C., Arnold W., Klein R.J., Parak F.G., Hulin P., Bergemann C., et al. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 2000, 60(December 1):6641-6648.
41. Durr S., Lyer S., Mann J., Janko C., Tietze R., Schreiber E., et al. Real-time cell analysis of human cancer cell lines after chemotherapy with functionalized magnetic nanoparticles. Anticancer Res. 2012, 32(May):1983-1989.
42. Chao X., Zhang Z., Guo L., Zhu J., Peng M., Vermorken A.J., et al. A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy. PLoS ONE 2012, 7:e40388.